Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 233Neoplasms 163Prostatic Neoplasms 143Colorectal Neoplasms 105Lung Neoplasms 97Leukemia, Myeloid, Acute 74Pancreatic Neoplasms 72Carcinoma, Non-Small-Cell Lung 71Multiple Myeloma 61Brain Neoplasms 58Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Melanoma 51Glioblastoma 48Carcinoma, Hepatocellular 45Ovarian Neoplasms 44Head and Neck Neoplasms 43Uterine Cervical Neoplasms 41Neoplasm Metastasis 41Sarcoma 40Glioma 39Stomach Neoplasms 37Hematologic Neoplasms 37Squamous Cell Carcinoma of Head and Neck 35Recurrence 35Lymphoma, Non-Hodgkin 34Carcinoma, Renal Cell 34Esophageal Neoplasms 33Lymphoma 32Leukemia 32Rectal Neoplasms 31

Interventions

Vincristine 1Vinblastine 1Topotecan 1Methotrexate 1Induction Chemotherapy 1Etoposide 1Erlotinib Hydrochloride 1Cyclophosphamide 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Choroid Plexus Neoplasms × 30 days × Clear all
NCT00602667 2026-05-19

Risk-Adapted Therapy for Young Children With Embryonal Brain Tumors, Choroid Plexus Carcinoma, High Grade Glioma or Ependymoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
293 enrolled 89 charts
CNS

Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡